A ‘cure’ for haemophilia is one step closer, following results of a groundbreaking gene therapy trial led by the NHS in London.
Clinical researchers at Barts Health NHS Trust and Queen Mary University of London have found that over one year on from a single treatment with a gene therapy drug, participants with haemophilia A (the most common type) are showing normal levels of the previously missing protein, and effectively curing them.
A single infusion of the gene therapy drug showed improved levels of the essential blood clotting protein Factor VIII, with 85 per cent of patients achieving normal or near-normal Factor VIII levels even many months after treatment.
The ‘transformational’ results have particular significance as the first successful gene therapy trial for the haemophilia A.
A hereditary genetic condition
There are around 2000 people with severe haemophilia A in the UK. A hereditary genetic condition dominantly affecting men, people with severe haemophilia A have virtually none of the protein factor VIII which is essential for blood to clot. It puts those affected at risk of excessive bleeding even from the slightest injury as well as causing spontaneous internal bleeding, which can be life-threatening. Recurring bleeding into joints can also lead to progressive joint damage and arthritis. The only current treatment involves multiple weekly injections to control and prevent bleeding, but there is no cure.
The trial saw patients across England injected with a copy of the missing gene, which allows their cells to produce the missing clotting factor. Following patients for up to nineteen months, tests show that eleven out of thirteen patients in the trial now have normal or near normal levels of the previously missing factor and all thirteen patients have been able to stop their previously regular treatment.
Professor John Pasi, Haemophilia Centre Director at Barts Health NHS Trust and Professor of Haemostasis and Thrombosis at Queen Mary University of London explained: “We have seen mind-blowing results which have far exceeded our expectations. When we started out we thought it would be a huge achievement to show a five per cent improvement, so to actually be seeing normal or near normal factor levels with dramatic reduction in bleeding is quite simply amazing. We really now have the potential to transform care for people with haemophilia using a single treatment for people who at the moment must inject themselves as often as every other day. It is so exciting.”
The team will now hold further tests widening participants globally to include people in the USA, Europe, Africa and South America.
Professor Pasi continued: “Incredibly exciting is the potential for a significant change in how haemophilia is treated globally. A single dose of medication that can so dramatically improve the lives of patients across the world is an amazing prospect.”
Professor Jo Martin, President, The Royal College of Pathologists said: “Pathology research is often responsible for ground-breaking developments in diagnoses and treatments that transform the lives of patients.
“What is truly remarkable about this revolutionary new gene therapy are the profound life-changing effects it offers patients with haemophilia. We would like to congratulate College fellow, Professor Pasi, and his team at Barts Health NHS Trust and Queen Mary University of London for their work in creating a simple but transformational treatment for patients.”
Jake Omer, 29 lives in Billericay and is married with two children, aged 3 years and a baby of 5 weeks. Diagnosed at two years old, he has had frequent injections of factor VIII to prevent bleeds ever since. Before he was treated with the gene therapy, Jake would wake up early before work to inject three times a week as well as injecting whenever he had an injury to stop the bleeding. As a result of of repeated bleeding Jake has arthritis in his ankles. His father is a Turk-Cypriot and as a child he and his family could never travel to visit relatives in case he needed medical care as the facilities wouldn’t have been available.
Jake said: “The gene therapy has changed my life. I now have hope for my future. It is incredible to now hope that I can play with my kids, kick a ball around and climb trees well into my kids’ teenage years and beyond. The arthritis in my ankles meant I used to worry how far I would be able to walk once I turned 40. At 23 I struggled to run 100m to catch a bus; now at 29 I’m walking two miles every day which I just couldn’t have done before having the gene therapy treatment.
“It’s really strange to not have to worry about bleeding or swellings. The first time I noticed a difference was about four months after the treatment when I dropped a weight in the gym, bashing my elbow really badly. I started to panic thinking this is going to be really bad, but after icing it that night I woke up and it looked normal. That was the moment I saw proof and knew that the gene therapy had worked.”
The Latest on: Haemophilia
- Decision to deny visa to boy with disabilities set to be overturnedon January 23, 2020 at 1:33 pm
Three-year-old Kayban Jamshaad was born in a Western Australian hospital in July 2016 and diagnosed with severe haemophilia and an acquired brain injury. He had previously been denied a temporary visa ...
- Kayban Jamshaad, WA child facing deportation over disability, offered hope in form of waiveron January 22, 2020 at 11:46 pm
The family of Kayban Jamshaad, who was born in WA but was facing deportation to the Maldives due to his disability, celebrates an "important" ruling that will likely now afford him a three-year visa.
- Contaminated blood: Psychology service for victims startson January 22, 2020 at 8:33 am
A specialist psychological support service for people affected by the contaminated blood scandal has begun. Thousands of people with haemophilia, including at least 300 from Wales, were infected with ...
- Shortage of haemophilia medicines across Keralaon January 18, 2020 at 10:48 pm
Nearly 2,000 haemophilia patients, including infants, depend on these medicine stores for the medicine. The haemophilia centre at the district hospital in Aluva alone has 984 patients, including ...
- Bone and Joint Center specilaised clinic helps improve haemophilic patients’ careon January 18, 2020 at 4:00 pm
Tribune News NetworkDohaA specialised multidisciplinary clinic that is helping individuals with haemophilia to prevent musculoskeletal complications, has cared for more than 25 patients since its ...
- HMC Center provides streamlined orthopaedic care for haemophilia patientson January 18, 2020 at 11:37 am
A specialised multidisciplinary clinic that is helping individuals with haemophilia to prevent musculoskeletal complications has cared for more than 25 patients since being established last November.
- Shortage of medicines: Stir by haemophilia patients on Saturdayon January 17, 2020 at 5:22 pm
KOCHI: Haemophilia patients and their relatives will stage a protest in front of the government hospital at Aluva here on Saturday in protest against the shortage of haemophilia medicines in Karunya ...
- Panic as salesman goes missing, vehicle found abandonedon January 17, 2020 at 4:52 am
THE FAMILY of missing Shane Ramjattan wants him home. Ramjattan suffers from haemophilia and a cut for him could be fatal. “I just want him home unharmed. I want to talk to him,” his mother ...
- Bombshell review: How life at Fox News became a horror showon January 17, 2020 at 12:52 am
On July 21, Ailes was out, receiving a $40 million pay-off. Suffering from haemophilia, he died less than a year later, after a fall, aged 77. These events, which preceded by a year the October 2017 ...
- Shortage of medicines puts haemophilia patients at riskon January 16, 2020 at 4:57 pm
KOCHI: Karunya pharmacies in the state are fast running out of haemophilia medicines, putting the lives of the hundreds of patients in danger. Parents of Madhav C P, a four-year-old Kochi boy with ...
via Google News and Bing News